RoA PCR-based Infectious Diseases Market to 2032
Overview
The RoA PCR-based Infectious Diseases Market is expected to reach a 64.84 USD Million by 2032 and is projected to grow at a CAGR of 7.49% from 2025 to 2032.
Revenue, 2024 (USD Million)
40.64
Forecast, 2032 (USD Million)
64.84
CAGR, 2024 - 2032
7.49%
Report Coverage
RoA
RoA PCR-based Infectious Diseases Market 2018-2032 USD Million
RoA PCR-based Infectious Diseases Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 40.64 USD Million
- Projected Market Size (2032): 64.84 USD Million
- CAGR (2025-2032): 7.49%
Key Findings of RoA PCR-based Infectious Diseases Market
- The RoA PCR-based Infectious Diseases Market was valued at 40.64 USD Million in 2024.
- The RoA PCR-based Infectious Diseases Market is likely to grow at a CAGR of 7.49% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Laboratory Based Testing in Testing Segment accounted for the largest share of the market with a revenue of 25.67 USD Million
- The fastest growing segment Tuberculosis PCR Test in Test Type Segment grew Fastest with a CAGR of 9.47% during the forecast period from 2024 to 2032.
RoA PCR-based Infectious Diseases Market Scope
RoA PCR-based Infectious Diseases Market Segmentation & Scope
End User
- Others
- Home Healthcare
- Academic And Research Institutes
- Community Health Centers
- Clinics
- Hospital
- Diagnostic Centers
Testing
- Point of Care Testing
- Laboratory Based Testing
Patient Type
- Adults
- Pediatric
- Geriatric
PCR Technology
- Others
- Multiplex PCR
- RT PCR
Infection
- Other Infections
- Hospital Acquired Infections
- Sexually Transmitted infection
- Respiratory Tract Infection
- Viral Infection
Test Type
- Others PCR Test
- Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
- Mycoplasma Genitalium (Mg) PCR Test
- Enterococcus PCR Test
- Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
- C.Difficile (Clostridium Difficile) PCR Test
- Norovirus PCR Test
- Sars (Covid-19) PCR Test
- H. Pylori PCR Test
- Bordetella PCR Test
- Rotavirus PCR Test
- Salmonellosis PCR Test
- Gonorrhea PCR Test
- Chlamydia Trachomatis Genital PCR Test
- Human Papillomavirus (Hpv) PCR Test
- Influenza PCR Test
- Human Immunodeficiency Virus (Hiv) PCR Test
- Hepatitis PCR Test
- Tuberculosis PCR Test
Pathogen
- Others
- Protozoa
- Fungal
- Bacterial
- Viral
RoA PCR-based Infectious Diseases Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 40.64 USD Million |
| Market Value in 2032 | 64.84 USD Million |
| CAGR (2025-2032) | 7.49% |
| Historic Data | 2016-2023 |
| Market Segments Covered | End User,Testing,Patient Type,PCR Technology,Infection,Test Type,Pathogen |
Regional Insights:
-
Leading Market (2024-2032): RoA, leading in terms of revenue 40.64 USD Million in 2024
- Key Country: RoA, leading in terms of revenue with value of 40.64 USD Million in 2024.
Segments and Scope
-
RoA PCR-based Infectious Diseases Market to 2032, By End User
- Diagnostic Centers is the largest segment in RoA PCR-based Infectious Diseases Market to 2032 with a revenue of 11.68 USD Million in the year 2024.
- Diagnostic Centers is the Fastest growing segment in RoA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 9.07 % in forecast period 2025-2032.
-
RoA PCR-based Infectious Diseases Market to 2032, By Testing
- Laboratory Based Testing is the largest segment in RoA PCR-based Infectious Diseases Market to 2032 with a revenue of 25.67 USD Million in the year 2024.
- Laboratory Based Testing is the Fastest growing segment in RoA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 7.76 % in forecast period 2025-2032.
-
RoA PCR-based Infectious Diseases Market to 2032, By Patient Type
- Geriatric is the largest segment in RoA PCR-based Infectious Diseases Market to 2032 with a revenue of 17.54 USD Million in the year 2024.
- Geriatric is the Fastest growing segment in RoA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 8.24 % in forecast period 2025-2032.
-
RoA PCR-based Infectious Diseases Market to 2032, By PCR Technology
- RT PCR is the largest segment in RoA PCR-based Infectious Diseases Market to 2032 with a revenue of 18.00 USD Million in the year 2024.
- RT PCR is the Fastest growing segment in RoA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 8.26 % in forecast period 2025-2032.
-
RoA PCR-based Infectious Diseases Market to 2032, By Infection
- Viral Infection is the largest segment in RoA PCR-based Infectious Diseases Market to 2032 with a revenue of 18.17 USD Million in the year 2024.
- Viral Infection is the Fastest growing segment in RoA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 8.11 % in forecast period 2025-2032.
-
RoA PCR-based Infectious Diseases Market to 2032, By Test Type
- Tuberculosis PCR Test is the largest segment in RoA PCR-based Infectious Diseases Market to 2032 with a revenue of 6.28 USD Million in the year 2024.
- Tuberculosis PCR Test is the Fastest growing segment in RoA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 9.47 % in forecast period 2025-2032.
-
RoA PCR-based Infectious Diseases Market to 2032, By Pathogen
- Viral is the largest segment in RoA PCR-based Infectious Diseases Market to 2032 with a revenue of 17.43 USD Million in the year 2024.
- Viral is the Fastest growing segment in RoA PCR-based Infectious Diseases Market to 2032 with a Growth rate of 7.86 % in forecast period 2025-2032.
RoA PCR-based Infectious Diseases Market Company Share Analysis
RoA PCR-based Infectious Diseases Market Geographical Sales Distribution, 2018-2032 USD Million
RoA PCR-based Infectious Diseases Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoA PCR-based Infectious Diseases Market is segmented based on Segmentation End User,Testing,Patient Type,PCR Technology,Infection,Test Type,Pathogen.
RoA PCR-based Infectious Diseases Market was valued at USD 40.64(Revenue in USD Million) in 2022.
RoA PCR-based Infectious Diseases Market is projected to grow at a CAGR of 7.49% during the forecast period of 2024 to 2032.
The Laboratory Based Testing segment is expected to dominate the RoA PCR-based Infectious Diseases Market, holding a largest market share of 25.67 USD Million in 2024
RoA PCR-based Infectious Diseases Market Scope
RoA PCR-based Infectious Diseases Market Segmentation & Scope
End User
- Others
- Home Healthcare
- Academic And Research Institutes
- Community Health Centers
- Clinics
- Hospital
- Diagnostic Centers
Testing
- Point of Care Testing
- Laboratory Based Testing
Patient Type
- Adults
- Pediatric
- Geriatric
PCR Technology
- Others
- Multiplex PCR
- RT PCR
Infection
- Other Infections
- Hospital Acquired Infections
- Sexually Transmitted infection
- Respiratory Tract Infection
- Viral Infection
Test Type
- Others PCR Test
- Methicillin-Resistant Staphylococcus Aureus (Mrsa) PCR Test
- Mycoplasma Genitalium (Mg) PCR Test
- Enterococcus PCR Test
- Carbapenem-Resistant Enterobacteriaceae (Cre) PCR Test
- C.Difficile (Clostridium Difficile) PCR Test
- Norovirus PCR Test
- Sars (Covid-19) PCR Test
- H. Pylori PCR Test
- Bordetella PCR Test
- Rotavirus PCR Test
- Salmonellosis PCR Test
- Gonorrhea PCR Test
- Chlamydia Trachomatis Genital PCR Test
- Human Papillomavirus (Hpv) PCR Test
- Influenza PCR Test
- Human Immunodeficiency Virus (Hiv) PCR Test
- Hepatitis PCR Test
- Tuberculosis PCR Test
Pathogen
- Others
- Protozoa
- Fungal
- Bacterial
- Viral
Frequently Asked Questions
The RoA PCR-based Infectious Diseases Market is segmented based on Segmentation End User,Testing,Patient Type,PCR Technology,Infection,Test Type,Pathogen.
RoA PCR-based Infectious Diseases Market was valued at USD 40.64(Revenue in USD Million) in 2022.
RoA PCR-based Infectious Diseases Market is projected to grow at a CAGR of 7.49% during the forecast period of 2024 to 2032.
The estimated market value of the RoA PCR-based Infectious Diseases Market for final year is USD 64.84 (USD Million).
RoA PCR-based Infectious Diseases Market Company Profiling
Frequently Asked Questions
The RoA PCR-based Infectious Diseases Market is segmented based on Segmentation End User,Testing,Patient Type,PCR Technology,Infection,Test Type,Pathogen.
RoA PCR-based Infectious Diseases Market was valued at USD 40.64(Revenue in USD Million) in 2022.
RoA PCR-based Infectious Diseases Market is projected to grow at a CAGR of 7.49% during the forecast period of 2024 to 2032.
The estimated market value of the RoA PCR-based Infectious Diseases Market for final year is USD 64.84 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.